Increased Healthcare-Associated Infections: The COVID-19 Impact on Hospital Infection Prevention
April 22nd 2024Monika Pogorzelska-Maziarz, epidemiologist, health services researcher, and associate professor at Thomas Jefferson University, shares insights on COVID-19's influence in acute care hospitals at this year’s Society for Healthcare Epidemiology of America (SHEA) conference.
Read More
Study Reveals Transmission of Candida auris from Adults to Children in Maryland Hospital
April 17th 2024The results were presented at the Society for Healthcare Epidemiology of America (SHEA) conference, highlighting this first documented case of C auris moving from an adult to a pediatric unit within the state.
Read More
Clostridioides Difficile Infection Testing Patterns and Outcomes Following Laxative Administration
April 17th 2024A study, presented at the Society for Healthcare Epidemiology of America (SHEA) conference, assesses laxative administration before CDI testing in Veteran Affairs (VA) hospitals and explores the demographic and contextual factors with non-adherence to guidelines.
Read More
This year at the Conference on Retroviruses and Opportunistic Infections (CROI), Lenacapavir shows virological suppression, Remdesivir reduces long covid risks, Bulevirtide benefits chronic HBV, HIV treatment enhances outcomes, vaginal ring or oral pre-exposure prophylaxis safe for HIV prevention throughout pregnancy.
Read More
New Formulation of Cabotegravir for HIV Treatment Can be Dosed at Intervals of at Least 4 Months
March 4th 2024In a phase 1 study, the investigational therapy known as cabotegravir ultra long-acting (CAB-ULA), showed positive pharmacokinetic, tolerability, and safety data supporting a prospective move to the next stage of clinical development.
Read More
A Strategy for Reducing STIs Through Implementing Doxycycline Post-Exposure Prophylaxis
March 4th 2024Study presented at CROI 2024 reveals that the introduction of Doxycycline post-exposure prophylaxis (doxy-PEP) guidelines in San Francisco has significantly decreased the incidence of chlamydia and syphilis
Read More
Changing the Antibiotic Reimbursement Model to Encourage Drug Development Proliferation
November 12th 2023Although the current reimbursement model makes it difficult for pharmaceutical companies to recoup their investments, a subscription model like the prospective congressional bill, the Pasteur Act, may help change that paradigm. In addition, there are international measures being carried out that may bring about changes.
Watch